Physician profile
Sonia Monga
NPI 1851552392
$7,757.17
in general payments reported to CMS, 2019-2025
65 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,582 · 2020: $1,057 · 2021: $841 · 2022: $776 · 2023: $1,147 · 2024: $1,201 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,500.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,739.11 | 2019-2025 | |
| Amgen INC. | $1,410.69 | 2019-2025 | Evenity, Prolia, Prolia |
| Astellas Pharma US INC | $577.35 | 2019-2025 | Veozah, Myrbetriq |
| Allergan, INC. | $344.43 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $273.48 | 2019-2025 | |
| Pfizer INC. | $258.36 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $256.86 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $228.29 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $175.15 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $173.57 | 2022-2025 | Rexulti |
| Abbott Laboratories | $160.15 | 2019-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $135.78 | 2025 | Gemtesa, Myfembree |
| Radius Health, INC. | $124.14 | 2020-2025 | Tymlos |
| Lilly USA, LLC | $93.83 | 2019-2023 | Jardiance, Mounjaro, Emgality |
| Novo Nordisk INC | $91.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Monga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.